Afala® Tablets 100 pcs – Prostate Support for BPH, Prostatitis

Afala® Tablets 100 pcs – Prostate Support for BPH, Prostatitis

Afala® Tablets 100 pcs is a unique therapeutic preparation developed to help support prostate health and manage symptoms commonly associated with prostate enlargement and inflammation in adult men. Formulated with affinity-purified antibodies to prostate-specific antigen (PSA), Afala targets processes that may contribute to benign prostatic hyperplasia (BPH) and chronic prostatitis — two of the most frequent urological conditions affecting men as they age.

How Afala Works

Afala® functions through a specialized mechanism that aims to modify the functional activity of the body’s own PSA. PSA is a protein naturally produced by prostate cells; in men with BPH or prostatitis, its regulatory role can be dysregulated, contributing to tissue dysfunction, inflammation, and discomfort. The active component in Afala — affinity-purified antibodies against PSA — helps:

• Reduce inflammation and edema (swelling) in prostate tissue

• Improve urodynamic performance and urinary flow

• Normalize lower urinary tract tone

• Alleviate dysuric symptoms such as frequent urination (including nocturia), difficulty in starting or maintaining a urine stream, and discomfort in the perineal area

These combined effects support overall prostate function, which can enhance urinary comfort and quality of life for men experiencing these conditions.

Key Benefits

Supports Prostate Health: May help reduce swelling and inflammation of the prostate gland.
Improves Urinary Function: Helps support smoother urination and better residual urine clearance.
Reduces Dysuric Symptoms: Addresses common symptoms such as frequent urge to urinate, pain or discomfort during urination, and nocturia.
Natural Functional Mechanism: Uses antibodies designed to interact with PSA regulatory pathways.
Convenient Oral Tablets: 100-tablet pack suitable for prolonged courses of therapy.

Who Can Benefit

Afala® is typically recommended for adult men who:

• Have benign prostatic hyperplasia (BPH stage I and II)

• Experience recurrent or chronic prostatitis symptoms

• Suffer from mild to moderate urinary discomfort, including frequent urination, difficulty starting or maintaining flow, or residual urine sensation

• Are seeking supportive therapy as part of a comprehensive prostate health plan

It’s important to note that Afala® is not intended for use by women or individuals under 18 years due to lack of study and approval for those populations.

How to Use

Afala® Tablets are intended to be taken orally as directed:

• Dosage: Typically 2 tablets per dose, taken twice daily — in the morning and evening.

• Administration: Tablets should be kept in the mouth until completely dissolved rather than swallowed whole.

• Duration: A recommended course is up to 16 weeks; in certain cases, longer durations may be advised by a healthcare provider.

• Follow medical guidance for severe symptoms or tailored dosing.

Safety & Precautions

Afala® is generally well-tolerated when used as directed, but users should observe the following:

✔ Pregnancy & Breastfeeding: Not intended for use in women.
✔ Children & Adolescents: Not recommended under 18 years of age due to insufficient safety data.
✔ Lactose Intolerance: Contains lactose monohydrate; those with galactose intolerance, glucose-galactose malabsorption, or lactase deficiency should consult a professional.
✔ Allergic Reactions: Discontinue use and seek medical advice if hypersensitivity or allergic reactions occur.
✔ Storage: Store in a cool, dry place at temperatures not exceeding 25 °C and keep out of reach of children.

As with any therapeutic product, consulting a healthcare provider before starting Afala® is advisable — especially for individuals on concurrent medications or with underlying health conditions.

Clinical Considerations

Afala®’s antibody-based mechanism is aimed at influencing prostate physiology rather than merely masking symptoms. Clinical observations suggest that long-term use within recommended guidelines may result in decreased prostate enlargement and improved urinary performance, potentially reducing dependence on symptomatic relief alone.

It’s suitable for both standalone use and as part of a broader prostate health management strategy that may include lifestyle modifications, hydration optimization, regular exercise, and routine medical check-ups.